Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Neoplasms of the CNS

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 33 articles: HTML format

Single Articles

April 2025
1. WANG Z, Zou P, Chen Z, Hou J, et al
   Novel strategy to target glioblastoma-initiating cells using a braintropic adeno-associated virus carrying a miR-dependent genome-editing system.
   Br J Cancer. 2025 Apr 12. doi: 10.1038/s41416-025-03007.
   PubMed     Abstract available
   
   
   March 2025
2. STRASSHEIMER F, Elleringmann P, Ludmirski G, Roller B, et al
   CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma.
   Br J Cancer. 2025 Mar 18. doi: 10.1038/s41416-025-02977.
   PubMed     Abstract available
   
   
   
3. STEINDL A, Zach C, Berchtold L, Grisold A, et al
   Prognostic relevance of the neurological symptom burden in brain metastases from breast cancer.
   Br J Cancer. 2025 Mar 1. doi: 10.1038/s41416-025-02967.
   PubMed     Abstract available
   
   
   October 2024
4. SERRA R, Smith SJ, Rowlinson J, Gorelick N, et al
   Neurosurgical application of olaparib from a thermo-responsive paste potentiates DNA damage to prolong survival in malignant glioma.
   Br J Cancer. 2024 Oct 22. doi: 10.1038/s41416-024-02878.
   PubMed     Abstract available
   
   
   September 2024
5. ZHANG ZS, Gao ZX, He JJ, Ma C, et al
   Andrographolide sensitizes glioma to temozolomide by inhibiting DKK1 expression.
   Br J Cancer. 2024 Sep 12. doi: 10.1038/s41416-024-02842.
   PubMed     Abstract available
   
   
   
6. SEIBOLDT T, Zeiser C, Nguyen D, Celikyurekli S, et al
   Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours.
   Br J Cancer. 2024;131:763-777.
   PubMed     Abstract available
   
   
   August 2024
7. ROA P, Foglizzo V, Harada G, Repetto M, et al
   Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents.
   Br J Cancer. 2024;131:601-610.
   PubMed     Abstract available
   
   
   June 2024
8. QI L, Du Y, Huang Y, Kogiso M, et al
   CD57 defines a novel cancer stem cell that drive invasion of diffuse pediatric-type high grade gliomas.
   Br J Cancer. 2024 Jun 4. doi: 10.1038/s41416-024-02724.
   PubMed     Abstract available
   
   
   May 2024
9. YANG L, Yi J, He W, Kong P, et al
   Death receptors 4/5 mediate tumour sensitivitNot applicably to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer.
   Br J Cancer. 2024 May 25. doi: 10.1038/s41416-024-02673.
   PubMed     Abstract available
   
   
   February 2024
10. CAO Q, Hajosch A, Kast RE, Loehmann C, et al
    Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.
    Br J Cancer. 2024 Feb 23. doi: 10.1038/s41416-024-02608.
    PubMed     Abstract available
    
    
    
11. CHIANG JY, Wei ST, Chang HJ, Chen DC, et al
    ABCC4 suppresses glioblastoma progression and recurrence by restraining cGMP-PKG signalling.
    Br J Cancer. 2024 Feb 12. doi: 10.1038/s41416-024-02581.
    PubMed     Abstract available
    
    
    
12. PRETE AA, Angerilli V, Bergamo F, Vettore V, et al
    HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study.
    Br J Cancer. 2024 Feb 12. doi: 10.1038/s41416-023-02569.
    PubMed     Abstract available
    
    
    
13. MOGENSEN H, Tettamanti G, Frederiksen LE, Talback M, et al
    Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden.
    Br J Cancer. 2024;130:260-268.
    PubMed     Abstract available
    
    
    
14. FLECCHIA C, Auclin E, Alouani E, Mercier M, et al
    Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
    Br J Cancer. 2024;130:442-449.
    PubMed     Abstract available
    
    
    January 2024
15. HEYMER EJ, Hawkins MM, Winter DL, Teepen JC, et al
    Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
    Br J Cancer. 2024 Jan 19. doi: 10.1038/s41416-024-02577.
    PubMed     Abstract available
    
    
    
16. HALLAL SM, Tuzesi A, Sida LA, Xian E, et al
    Glioblastoma biomarkers in urinary extracellular vesicles reveal the potential for a 'liquid gold' biopsy.
    Br J Cancer. 2024 Jan 11. doi: 10.1038/s41416-023-02548.
    PubMed     Abstract available
    
    
    
17. JOO JE, Chu YL, Georgeson P, Walker R, et al
    Intratumoral presence of the genotoxic gut bacteria pks(+) E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer.
    Br J Cancer. 2024 Jan 10. doi: 10.1038/s41416-023-02554.
    PubMed     Abstract available
    
    
    November 2023
18. TRIVEDI R, Bhat KP
    Liquid biopsy: creating opportunities in brain space.
    Br J Cancer. 2023;129:1727-1746.
    PubMed     Abstract available
    
    
    October 2023
19. THOMAS EM, Wright JA, Blake SJ, Page AJ, et al
    Advancing translational research for colorectal immuno-oncology.
    Br J Cancer. 2023;129:1442-1450.
    PubMed     Abstract available
    
    
    September 2023
20. VANDERLINDEN A, Jones CG, Myers KN, Rominiyi O, et al
    DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells.
    Br J Cancer. 2023 Sep 30. doi: 10.1038/s41416-023-02454.
    PubMed     Abstract available
    
    
    
21. CHENG S, McLaughlin JR, Brown MC, Al-Sawaihey H, et al
    Correction: Maternal and childhood medical history and the risk of childhood brain tumours: a case-control study in Ontario, Canada.
    Br J Cancer. 2023 Sep 13. doi: 10.1038/s41416-023-02415.
    PubMed    
    
    
    
22. HVIDTFELDT UA, Chen J, Rodopoulou S, Strak M, et al
    Long-term air pollution exposure and malignant intracranial tumours of the central nervous system: a pooled analysis of six European cohorts.
    Br J Cancer. 2023;129:656-664.
    PubMed     Abstract available
    
    
    August 2023
23. NTAFOULIS I, Kleijn A, Ju J, Jimenez-Cowell K, et al
    Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers.
    Br J Cancer. 2023 Aug 24. doi: 10.1038/s41416-023-02402.
    PubMed     Abstract available
    
    
    
24. ZHAN Y, Song Y, Qiao W, Sun L, et al
    Focused ultrasound combined with miR-1208-equipped exosomes inhibits malignant progression of glioma.
    Br J Cancer. 2023 Aug 14. doi: 10.1038/s41416-023-02393.
    PubMed     Abstract available
    
    
    
25. PARK J, Shim JK, Lee M, Kim D, et al
    Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program.
    Br J Cancer. 2023 Aug 9. doi: 10.1038/s41416-023-02391.
    PubMed     Abstract available
    
    
    July 2023
26. LOPEZ J, Lai-Kwon J, Molife R, Welsh L, et al
    A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma.
    Br J Cancer. 2023 Jul 24. doi: 10.1038/s41416-023-02356.
    PubMed     Abstract available
    
    
    June 2023
27. ZHANG G, Zhu Q, Fu G, Hou J, et al
    Correction to: TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis.
    Br J Cancer. 2023 Jun 19. doi: 10.1038/s41416-023-02305.
    PubMed    
    
    
    May 2023
28. CHENG S, McLaughlin JR, Brown MC, Al-Sawaihey H, et al
    Maternal and childhood medical history and the risk of childhood brain tumours: a case-control study in Ontario, Canada.
    Br J Cancer. 2023 May 10. doi: 10.1038/s41416-023-02281.
    PubMed     Abstract available
    
    
    
29. CROMIE KJ, Hughes NF, Milner S, Crump P, et al
    Socio-economic and ethnic disparities in childhood cancer survival, Yorkshire, UK.
    Br J Cancer. 2023;128:1710-1722.
    PubMed     Abstract available
    
    
    April 2023
30. LYU L, Jiang Y, Ma W, Li H, et al
    Single-cell sequencing of PIT1-positive pituitary adenoma highlights the pro-tumour microenvironment mediated by IFN-gamma-induced tumour-associated fibroblasts remodelling.
    Br J Cancer. 2023;128:1117-1133.
    PubMed     Abstract available
    
    
    March 2023
31. KIANG KM, Tang W, Song Q, Liu J, et al
    Targeting unfolded protein response using albumin-encapsulated nanoparticles attenuates temozolomide resistance in glioblastoma.
    Br J Cancer. 2023 Mar 17. doi: 10.1038/s41416-023-02225.
    PubMed     Abstract available
    
    
    February 2023
32. WALLACE ND, Dunne MT, McArdle O, Small C, et al
    Efficacy and toxicity of primary re-irradiation for malignant spinal cord compression based on radiobiological modelling: a phase II clinical trial.
    Br J Cancer. 2023;128:576-585.
    PubMed     Abstract available
    
    
    September 2022
33. ABIKO K, Hamanishi J, Matsumura N, Mandai M, et al
    Dynamic host immunity and PD-L1/PD-1 blockade efficacy: developments after "IFN-gamma from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer".
    Br J Cancer. 2022 Sep 6. pii: 10.1038/s41416-022-01960.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.